Baten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, Deodhar A, Porter B, Martin R, Andersson M, Mpofu S, Richards HB, MEASURE 1 Study Group, MEASURE 2 Study Group.
Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis.
N Engl J Med 2015;373:2534-48. [Ref.ID 99800]